PF-07062119   Click here for help

GtoPdb Ligand ID: 11125

Compound class: Antibody
Comment: PF-07062119 is a bispecific T cell-engaging (BiTE) monoclonal antibody that is being developed by Pfizer [1]. It simultaneously binds to CD3ε on T cells and GUCY2C-positive cancer cells.
Click here for help
No information available.
Summary of Clinical Use Click here for help
PF-07062119 has commenced Phase 1 Safety and Tolerability evaluation in patients with selected advanced/metastatic gastrointestinal tumours.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04171141 Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. Phase 1 Interventional Pfizer